期刊文献+

1例肝移植术后耶氏肺孢子虫肺炎患者的药学监护 被引量:2

Participation of Clinical Pharmacist in the Therapy for One Case of Pneumocystis Jiroveci Pneumonia after Liver Transplantation
原文传递
导出
摘要 目的探讨肺部感染耶氏肺孢子虫患者的治疗方案及临床药师在感染治疗中的作用。方法临床药师参与1例肝移植术后肾功能不全患者感染耶氏肺孢子虫肺炎的治疗经过,同时查阅国内外文献,对耶氏肺孢子虫感染的临床表现、治疗方法进行分析。结果医师采纳临床药师建议,患者感染得到控制,病情好转出院。结论对于移植患者应早期识别耶氏肺孢子虫感染,轻度肾功能不全的患者可以考虑使用低剂量复方新诺明联合卡泊芬净治疗耶氏肺孢子虫肺炎。 OBJECTIVE To investigate the therapeutic regimen of pneumocystis jiroveci infection and the role of clinical pharmacists in the treatment of pneumocystis jiroveci infection.METHODS Clinical pharmacists participated in the treatment of pneumocystis jiroveci pneumonia in a patient with renal insufficiency after liver transplantation.Meanwhile,the clinical manifestations and treatment of pneumocystis jiroveci pneumonia infection were analyzed by reference to literature at home and abroad.RESULTS The doctor adopted the suggestion of clinical pharmacist,and the patient’s infection was controlled with the condition improved,and the patient was discharged.CONCLUSION Pneumocystis jiroveci infection shall be recognized early in transplant recipients.Patients with mild renal insufficiency may consider the use of low-dose combination of compound sulfamethoxazole and caspofungin in the treatment of pneumocystis jiroveci infection.
作者 杨戈 江灏 李薇 何菊英 YANG Ge;JIANG Hao;LI Wei;HE Juying(Department of Pharmacy,the First Hospital Affiliated to Army Medical University,Chongqing 400038,China)
出处 《中国现代应用药学》 CAS CSCD 北大核心 2019年第16期2084-2087,共4页 Chinese Journal of Modern Applied Pharmacy
关键词 感染 耶氏肺孢子虫肺炎 复方新诺明 卡泊芬净 infection pneumocystis jiroveci pneumonia sulfamethoxazole compound caspofungin
  • 相关文献

参考文献7

二级参考文献51

  • 1陈新谦 金有豫.新编药物学(第14版)[M].北京:人民卫生出版社,1997.487.
  • 2陈灏珠.实用内科学(第10版)[M].北京:人民卫生出版社,1997.1410-1413.
  • 3Edman JC, Kovacs JA, Masur H, et al. Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi [ J ]. Nature, 1988, 334(6182) :519 -522.
  • 4Stringer JR, Beard CB, Miller RF, et al. A new name ( Pneumocystis jiroveci) for Pneumocystis from humans [ J ]. Emerg Infect Dis, 2002, 8(9) :891 -896.
  • 5Kovacs JA, Masur H. Evolving health effects of Pneumocystis: one hundred years of progress in diagnosis and treatment [ J]. JAMA, 2009, 301(24):2578-2585.
  • 6de Boer MG, Bruijnesteijn van Coppenraet LE, Gaasbeek A, et al. An outbreak of Pneumocystis jiroveci pneumonia with 1 predominant genotype among renal transplant recipients: interhuman transmission or a common environmental source [ J ] .9 Clin Infect Dis, 2007, 44(9):1143 -1149.
  • 7Gigliotti F. Pneumoeystis carinii: has the name really been changed [ J ] ? Clin Infect Dis, 2005, 41 (12) : 1752 - 1755.
  • 8Cushion MT. Are members of the fungal genus pneumocystis (a) commensals; (b) opportunists ; (c) pathogens ; or (d) all of the above [J] ? PLoS Pathog, 2010, 6(9) :e1001009.
  • 9Ponce CA, Gallo M, Bustamante R, et al. Pneumocystis colonization is highly prevalent in the autopsied lungs of the general population [J]. Clin Infect Dis, 2010, 50(3):347-353.
  • 10Calderon EJ, Rivero L, Respaldiza N, et al. Systemic inflammation in patients with chronic obstructive pulmonary disease who are colonized with Pneumocystis jiroveci [ J]. Clin Infect Dis, 2007, 45(2) :e17-19.

共引文献69

同被引文献16

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部